This is the first study aimed to investigate the prevalence of polymorphisms of TGF-β and IFN-γ in leukocytes of patients with SIRS and to investigate its possible associations as a risk factor for development of AKI and death. This evidence concerns the gene TGFB1 and systemic inflammatory response syndrome.